The Italian Budget Law for 2024 enacted on 30 December 2023 and published under the identifier Law 30 December 2023 No. 213 in the Gazzetta Ufficiale della Repubblica Italiana introduces a significant restructuring of the regulatory framework governing products containing cannabidiol intended for inhalation.
Article 18 paragraph 3 of Law 213/2023 expressly modifies the scope of the State monopoly on tobacco products by extending it to include products for smoking or inhalation that do not contain tobacco but are composed of hemp or derivatives thereof including CBD and other cannabinoids.
The legislative text directly attaches this category of products to the distribution regime established by Legislative Decree 12 January 2016 No. 6 which transposed Directive 2014/40/EU into Italian law and which vests exclusive distribution competence in warehouse concession holders authorised by the Customs and Monopolies Agency.
This measure functionally transfers the entire wholesale distribution chain for CBD inhalation goods out of the general retail and specialist health shop sector and into a closed circuit controlled by State-licensed tobacco wholesalers operating under ADM oversight.
The law further provides that implementing decrees to be issued by the Ministry of Economy and Finance in concert with the Ministry of Health will define the technical modalities for product registration laboratory testing requirements and the application of the tobacco traceability system known as SRPF to CBD-containing products thereby aligning hemp-based inhalation products with the fiscal marking and authentication infrastructure already deployed for conventional tobacco and novel nicotine products.



